VHL and renal carcinoma: AL Harris's group also described a coordinated upregulation of miR-210 and downregulation of ISCU in renal carcinomas [38] but, in contrast to the data in paragangliomas, activation of this pathway was not correlated with VHL mutations and, thus, the connection between HIF and miR-210/ISCU remains unknown in this type of cancer.